SCHEMBL21345696

SCHEMBL21345696

c1ccc(-c2cc(-c3ccccc3)cc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccccc5)c5sc6c(-c7ccccc7)cc(-c7ccccc7)cc6c45)n3)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 1/20 0.34
▸ ADORA2A P29274 5/20 0.33
▸ ADORA1 P30542 5/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ADORA3 P0DMS8 2/20 0.33
▸ ADORA2B P29275 2/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ AXL P30530 2/20 0.32
▸ CDK8 P49336 1/20 0.32
▸ TNIK Q9UKE5 1/20 0.32
▸ POLB P06746 1/20 0.30
▸ MAPK10 P53779 1/20 0.30
▸ SGK1 O00141 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22524051 0.97 LIMK1 (0.34) LIMK1ADORA2AADORA1L3MBTL1ADORA3
SCHEMBL22524046 0.97 LIMK1 (0.35) LIMK1ADORA2AADORA1L3MBTL1ADORA3
SCHEMBL21345694 0.96 MEN1 (0.36) LIMK1ADORA2AADORA1L3MBTL1ADORA3
SCHEMBL22524014 0.96 MEN1 (0.36) LIMK1ADORA2AADORA1L3MBTL1ADORA3
SCHEMBL21345894 0.96 MEN1 (0.36) LIMK1ADORA2AADORA1L3MBTL1ADORA3
SCHEMBL21345695 0.95 LIMK1 (0.35) LIMK1ADORA2AADORA1L3MBTL1ADORA3
SCHEMBL22524015 0.95 LIMK1 (0.35) LIMK1ADORA2AADORA1L3MBTL1ADORA3
SCHEMBL21345896 0.94 LIMK1 (0.34) LIMK1ADORA2AADORA1L3MBTL1MEN1
SCHEMBL21345681 0.93 LIMK1 (0.36) LIMK1ADORA2AADORA1L3MBTL1ADORA3
SCHEMBL21345733 0.92 MEN1 (0.37) LIMK1ADORA2AADORA1L3MBTL1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11370782-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2022-06-28 — — US disclosed
US-20200317650-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2020-10-08 — — US disclosed
WO-2019172652-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2019-09-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11370782-B2 Compound and organic light emitting device comprising the same OXER1, ARL1, UBE2L3 LIMK1 565/4885ADORA2A 1932/4885ADORA1 799/4885
US-20200317650-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME OXER1, NR2E3, ORC3 LIMK1 551/4885ADORA2A 2007/4885ADORA1 820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback